EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Novartis AG (NVS) had EBIT Margin of 31.77% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$14.95B |
|
$3.26B |
|
$3.71B |
|
$11.24B |
|
$10.20B |
|
$4.75B |
|
$-481.00M |
|
$4.27B |
|
$4.27B |
|
$3.26B |
|
$3.26B |
|
$3.26B |
|
$3.26B |
|
$4.75B |
|
$6.16B |
|
1.91B |
|
1.91B |
|
$1.71 |
|
$1.71 |
|
| Balance Sheet Financials | |
$27.35B |
|
$10.69B |
|
$94.68B |
|
$122.03B |
|
$31.75B |
|
$37.49B |
|
$48.34B |
|
$80.09B |
|
$41.95B |
|
$-26.89B |
|
$41.95B |
|
1.90B |
|
| Cash Flow Statement Financials | |
$9.56B |
|
$-14.84B |
|
$1.56B |
|
$11.44B |
|
$7.62B |
|
$-3.82B |
|
$570.00M |
|
$-9.07B |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.86 |
|
-- |
|
-- |
|
0.47 |
|
1.12 |
|
75.19% |
|
31.77% |
|
|
EBIT Margin |
31.77% |
-- |
|
28.55% |
|
21.83% |
|
$8.92B |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.60 |
|
1.52 |
|
59.32 |
|
7.76% |
|
-12.11% |
|
2.67% |
|
4.10% |
|
$22.07 |
|
$4.66 |
|
$4.99 |
|